دورية أكاديمية

Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults

التفاصيل البيبلوغرافية
العنوان: Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults
المؤلفون: Catalina Rincón-Pérez, Désirée Larenas-Linnemann, Marco Antonio Figueroa-Morales, Jorge Luna-Pech, Linda García-Hidalgo, Alejandra Macías-Weinmann, Javier Gómez-Vera, José Fernando Barba-Gómez, Juan José Juan José Matta-Campos, Esther Guevara-Sangines, Fermín Jurado-Santacruz, Adriana López Tello-Santillán, José Antonio Ortega-Martell, Nancy Pulido-Díaz, Liliana Guadalupe Serrano-Jaén, Mirna Toledo-Bahena, Guadalupe Villanueva-Quintero, José Luis Mayorga-Butrón
المصدر: Revista Alergia México, Vol 65 suppl 1 (2018)
بيانات النشر: Colegio Mexicano de Inmunología Clínica y Alergia, A.C., 2018.
سنة النشر: 2018
المجموعة: LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: dermatitis atópica, ciclosporina a, tratamiento biológico, dupilumab, omalizumab, posición de consenso, Immunologic diseases. Allergy, RC581-607
الوصف: Background: The diagnostic approaches and therapeutic strategies of atopic dermatitis (AD) are generally inconsistent among physicians and health institutions. Objective: To develop a consensus statement among experts to reduce the variations in practice regarding the diagnosis and treatment of patients ≥ 12 years with AD to improve their care. Methods: Systematic literature search in PubMed and GREAT. With methodological support and using the Delphi method, a formal consensus was developed among 16 experts in Dermatology and Allergology, based on the current evidence and its applicability in the Mexican context. Apart from intense electronic communication, several issues of disagreement were discussed in two face-to-face meetings. Results: The clinical experts reached consensus on 46 statements related to the definition, classification, diagnostic strategies and treatment of AD. For the diagnosis we suggest the Williams criteria and for severity scoring the SCORAD (by the doctor) and POEM (by the patient). In addition to general care and treatment education (workshops), we suggest four steps for treatment, depending on severity: 1. Topical treatment with anti-inflammatory agents (and systemic: antihistamines/antileukotrienes —low level evidence—) 2. Phototherapy, 3. Cyclosporin A and 4. Dupilumab, with the possibility of managing this biological earlier on if a fast effect is needed. In extrinsic AD we suggest evaluating the addition of allergen immunotherapy or an elimination diet, if there is an IgE-mediated respiratory or food allergy, respectively. Conclusion: The panel of experts reached consensus on relevant aspects of AD with a focus on the transcultural adaptation of recent evidence.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Spanish; Castilian
تدمد: 0002-5151
2448-9190
العلاقة: http://revistaalergia.mx/ojs/index.php/ram/article/view/526Test; https://doaj.org/toc/0002-5151Test; https://doaj.org/toc/2448-9190Test
DOI: 10.29262/ram.v65i6.526
الوصول الحر: https://doaj.org/article/bd5efcaacd8d4c818c561c37d130c03cTest
رقم الانضمام: edsdoj.bd5efcaacd8d4c818c561c37d130c03c
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00025151
24489190
DOI:10.29262/ram.v65i6.526